The U.S. Intravascular Stents Market is expected to experience significant growth in the coming years. This growth can be attributed to factors such as increasing prevalence of cardiovascular diseases, rising adoption of minimally invasive procedures, and advancements in stent technologies. Additionally, growing geriatric population and changing lifestyle habits are also expected to drive market growth.
Two key growth drivers for the U.S. Intravascular Stents Market include the increasing demand for drug-eluting stents and the rising number of percutaneous coronary intervention procedures. Drug-eluting stents are preferred over bare-metal stents due to their ability to reduce the risk of restenosis. Furthermore, the increasing number of percutaneous coronary intervention procedures, coupled with technological advancements in stent design, is expected to propel market growth.
Largest Region
North America
35% Market Share in 2023
Get more details on this report -
However, the U.S. Intravascular Stents Market is not without its challenges. Two major industry restraints include the high cost associated with stent procedures and the stringent regulatory guidelines for product approval. The high cost of stent procedures can limit market growth, especially in developing regions where affordability is a concern. Additionally, stringent regulatory guidelines can hinder the introduction of new stent technologies in the market.
In terms of segment analysis, the U.S. Intravascular Stents Market can be divided into drug-eluting stents, bare-metal stents, and bioresorbable stents. Drug-eluting stents are expected to dominate the market due to their superior efficacy in reducing restenosis rates. However, bioresorbable stents are gaining traction due to their biodegradable nature and reduced risk of long-term complications.
Report Coverage & Deliverables
Historical Statistics
Growth Forecasts
Latest Trends & Innovations
Market Segmentation
Regional Opportunities
Competitive Landscape
In the competitive landscape, key players in the U.S. Intravascular Stents Market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, and Terumo Corporation, among others. These companies are focusing on product innovation, strategic collaborations, and mergers and acquisitions to maintain their market position and gain a competitive edge. Overall, the U.S. Intravascular Stents Market is poised for significant growth in the coming years, driven by technological advancements and increasing prevalence of cardiovascular diseases.